Improving the Efficacy of Quinolylnitrones for Ischemic Stroke Therapy, QN4 and QN15 as New Neuroprotective Agents after Oxygen-Glucose Deprivation/Reoxygenation-Induced Neuronal Injury
In our search for new neuroprotective agents for stroke therapy to improve the pharmacological profile of the compound quinolylnitrone QN23, we have prepared and studied sixteen new, related and easily available quinolylnitrones. As a result, we have identified compounds QN4 and QN15 as promising ca...
Guardat en:
Autors principals: | José M. Alonso (Autor), Alejandro Escobar-Peso (Autor), Israel Fernández (Autor), Alberto Alcázar (Autor), José Marco-Contelles (Autor) |
---|---|
Format: | Llibre |
Publicat: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Matèries: | |
Accés en línia: | Connect to this object online. |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
-
Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke
per: Emma Martínez-Alonso, et al.
Publicat: (2022) -
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
per: Beatriz Chamorro, et al.
Publicat: (2023) -
Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's Disease
per: José M. Alonso, et al.
Publicat: (2021) -
Sesquiterpene compound α-cyperone relieves the injury in neurons undergoing oxygen-glucose deprivation/reoxygenation
per: Jian Wang, et al.
Publicat: (2022) -
Neuroprotective effects of L-carnitine against oxygen-glucose deprivation in rat primary cortical neurons
per: Yu Jin Kim, et al.
Publicat: (2012)